Cases of the autoimmune skin condition eczema appear to rise in areas most plagued by air pollution, new research shows.

Eczema cases are rising in areas with high air pollution, according to a Yale University study. Exposure to fine particulate ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

The novel oral first-in-class anti-inflammatory agent has demonstrated robust efficacy and high safety margins in preclinical studies, and is the first drug candidate to advance to clinical trials ...

Atopic dermatitis is the most common type of eczema, affecting approximately 9.6 million children and 16.5 million adults in the United States. ZORYVE cream 0.15% was approved by the FDA for the ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing CohortInterim Data from Atopic Dermatitis Trial ...

SciBase is excited to announce a new collaboration aimed at revolutionizing early detection of atopic diseases in infants through the use of Electrical Impedance Spectroscopy (EIS) technology. This ...

In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.

AI has shown promise by analysing data from patient records to recognise complex patterns within large datasets, which can aid in the ...

Atopic dermatitis (AD), commonly referred to as eczema, is one of the most common inflammatory skin diseases, affects over 26 million people in the U.S. alone and up to 10% of adults worldwide. AD ...

If not controlled with the above measures, your eczema might require prescription treatments like corticosteroids or even ...